Elevra Lithium Ltd (ELVR) Form 20-F — Nov 2, 2026
Elevra Lithium filed its annual report on Form 20-F for fiscal year ended June 30, 2026, its first full year as the combined company following the August 2025 merger with Piedmont Lithium. The company reports 194,016,029 ordinary shares outstanding and trades on Nasdaq via ADSs (ELVR) representing 10 ordinary shares each, with ordinary shares listed on the ASX (ELV). The filing discloses a material weakness in internal control over financial reporting as of June 30, 2026, centered on user access and change management controls over Canadian systems, with a six-point remediation plan underway.
Key figures
- Shares Outstanding
- 194016029
- Ads ratio
- 1 ADS = 10 ordinary shares
- Mangrove supply
- 122,000 dmt year 1 and 144,000 dmt from year 2, take-or-pay, seven-year term
- Lg energy supply
- 240,000 dmt spodumene concentrate over three years plus up to 90,000 dmt optional
- Merger shares issued
- 11,565,602,304 Elevra ordinary shares (pre-consolidation)
- Merger cost synergies
- $15 million realized through June 30, 2026
- Nall expansion target
- ~315,000 dmt average annual spodumene concentrate production capacity
- Lcsc convertible notes
- C$145 million in two tranches (C$65 million closed July 31, 2026; C$80 million conditional)
- Contract note borrowing
- $29 million drawn under $30 million prepayment facility
- Share consolidation ratio
- 150:1 (effective September 16, 2025)
- Share purchase plan proceeds
- AU$15.56 million ($11.1 million) June 2026
- Institutional placement proceeds
- AU$275 million ($196 million) May 2026
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.